Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents

Completed · Early Phase 1

Conditions studied: Herpes Zoster, Allergy and Immunology, Corona Virus Infection

In brief

The purpose of this study is to measure the effect of the Shingrix vaccine on your immune system and whether that has any effect on the body's ability to fight off other infections such as COVID-19. We hypothesize that: H1: Shingrix vaccination will elevate acute and trained immunity H2: For 6 months following the first injection, increased levels of acute and trained immunity is associated with less disease, including fewer hospitalizations and deaths associated with flu, pneumonia, and COVID-19.

Key facts

Study ID
NCT04523246
Run by
University of Oklahoma
People needed
217
Starts
2020-09-01
Expected to finish
2023-05-19
Last updated by the study team
2023-11-22

Who can join

Age: 65 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.